Federal Funding Opportunities

Winship investigators have access to an extensive listing of cancer-related funding issued by the National Institutes of Health and other federal agencies. The listing updates automatically on a daily basis.

Use the column sorting, search filtering, and pagination tools to find and select federal funding opportunities below.

Cascade Link

Opportunity	Posted	Closing
NCI Outstanding Investigator Award (R35 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	08/16/19	11/06/19
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	08/16/19	06/08/22
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	08/16/19	06/08/22
Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R03 Clinical Trial Not Allowed) Agency: NIH Institutions: NIAID	08/16/19	07/16/22
Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NIAID	08/16/19	09/07/22
Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	08/12/19	06/08/22
Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	08/12/19	06/08/22
DoD Reconstructive Transplant Research Program, Qualitative Research Award Agency: AMRAA	08/12/19	10/16/19
Tribal Training Support for the Community and Tribal Air Quality Programs Agency: EPA	08/05/19	09/20/19
SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance (SB1, R44) Clinical Trial Not Allowed Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIAMSNIBIBNIDCDNIDCRNIDDKNIEHSNIGMSNIMHNINDSNINRNCATS	08/05/19	04/05/22
Revision Applications to Support the Application of Informatics Technology for Cancer Research (R01 Clinical Trials Optional) Agency: NIH Institutions: NCI	07/31/19	11/20/19
Revision Applications to Support the Application of Informatics Technology for Cancer Research (U01 Clinical Trials Optional) Agency: NIH Institutions: NCI	07/31/19	11/20/19
Revision Applications to Support the Application of Informatics Technology for Cancer Research (U24 Clinical Trials Optional) Agency: NIH Institutions: NCI	07/31/19	11/20/19
Human Exploration Research Opportunities (HERO) Agency: JSC	07/31/19	09/04/20
Participant Engagement and Cancer Genome Sequencing (PE-CGS): Coordinating Center (U24 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	07/30/19	07/30/20
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	07/30/19	02/11/22
Participant Engagement and Cancer Genome Sequencing (PE-CGS): Research Centers (U2C Clinical Trial Optional) Agency: NIH Institutions: NCI	07/26/19	07/30/20
Radiation Exposure Screening and Education Program Agency: HRSA	07/19/19	10/28/19
The NCI Predoctoral to Postdoctoral Fellow Transition Award (F99/K00) Agency: NIH Institutions: NCI	07/18/19	12/04/19
Cooperative Ecosystem Studies Unit, Pacific Northwest CESU Agency: USGS	07/10/19	08/23/19
Integrated Child Health and Social Services Award (ICHSSA) Agency: NIG	07/08/19	08/23/19
Maximizing the Scientific Value of Existing Biospecimen Collections: Scientific Opportunities for Exploratory Research (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: ODPNCINHLBINIAAANIDANIEHSCTP	07/08/19	03/08/21
Cancer Prevention Clinical Trials Network (CP-CTNet): CP-CTNet Sites (UG1 Clinical Trial Required) Agency: NIH Institutions: NCI	06/28/19	08/29/19
Novel Technology Tools to Facilitate Research Using Next Generation Patient-derived Cancer Models (U01 Clinical Trial Not Allowed) Agency: NIH	06/28/19	08/30/19
Mechanisms of Mycobacterial-Induced Immunity in HIV-Infected and/or Uninfected Individuals to Inform Innovative Tuberculosis Vaccine Design (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NIAID	06/28/19	01/14/22
Stimulating Innovations in Behavioral Intervention Research for Cancer Prevention and Control (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	06/28/19	09/07/22
DoD Melanoma Concept Award Agency: AMRAA	06/27/19	10/23/19
Early-Stage T1 Translational Aging Research (Bench to Bedside) for the Development of Novel Therapeutics (R33 Clinical Trial Optional) Agency: NIH Institutions: NIA	06/25/19	07/16/22
Early-Stage T1 Translational Aging Research (Bench to Bedside) for the Development of Novel Therapeutics (R21/R33 Clinical Trial Optional) Agency: NIH Institutions: NIA	06/25/19	07/16/22
DoD Kidney Cancer, Clinical Consortium Award Agency: AMRAA	06/18/19	10/01/19
DoD Kidney Cancer Academy of Kidney Cancer Investigators - Early-Career Investigator Award Agency: AMRAA	06/18/19	10/01/19
DoD Kidney Cancer, Academy of Kidney Cancer Investigators - Dean Leadership Award Agency: AMRAA	06/18/19	10/01/19
"Clinical Trials" on a Chip: Tissue Chips to Inform Clinical Trial Design and Implementation in Precision Medicine (UG3/UH3 - Clinical Trial Not Allowed) Agency: NIH Institutions: NCATSNCINIAMSNICHDNIDCR	06/12/19	10/09/19
NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	06/05/19	10/18/19
NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	06/05/19	10/18/19
DoD Kidney Cancer, Concept Award Agency: AMRAA	05/31/19	10/01/19
DoD Kidney Cancer, Idea Development Award Agency: AMRAA	05/31/19	10/01/19
DoD Kidney Cancer, Translational Research Partnership Award Agency: AMRAA	05/31/19	10/01/19
Immunobiology of Xenotransplantation (U01 Clinical Trial Not Allowed) Agency: NIH Institutions: NIAID	05/30/19	09/16/19
Immunobiology of Xenotransplantation (U19 Clinical Trial Not Allowed) Agency: NIH Institutions: NIAID	05/30/19	09/16/19
Interaction of Ionizing Radiation with Matter University Research Alliance (IIRM-URA) Agency: DTRA	05/30/19	09/30/20
DoD Vision, Translational Research Award Agency: AMRAA	05/24/19	12/06/19
Research Projects in Cancer Systems Biology (U01 Clinical Trial Optional) Agency: NIH Institutions: NCI	05/22/19	11/15/21
Postdoctoral Research Associate Training (PRAT) Program (Fi2) Agency: NIH Institutions: NIGMS	05/21/19	10/04/21
Methods to Improve Reproducibility of Human iPSC Derivation, Growth and Differentiation (SBIR) (R44 Clinical Trial Not Allowed) Agency: NIH Institutions: NIGMSNCINHLBINIAAANIAIDNIAMSNIBIBNIDCRNIDDKNIDANIEHSNCATS	05/21/19	01/06/20
DoD Melanoma, Idea Award Agency: AMRAA	05/16/19	10/23/19
DoD Melanoma, Team Science Award Agency: AMRAA	05/16/19	10/23/19
DoD Melanoma, Translational Research Award Agency: AMRAA	05/16/19	10/23/19
Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions (D43 Clinical Trial Optional) Agency: NIH Institutions: FICNCINIDANIMH	05/14/19	08/20/21
Provocative Questions (PQs) in Multiple Myeloma Disparities Research (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	05/13/19	11/15/20
Provocative Questions (PQs) in Multiple Myeloma Disparities Research (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	05/13/19	11/15/20
Exploratory Grants in Cancer Epidemiology (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	05/08/19	10/08/21
Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed) Agency: NIH Institutions: NCINHGRINIANIAAANICHDNIDCRNIDANIEHSNIMHNINDSFICODPOBSSRORWH	05/08/19	05/07/22
Dissemination and Implementation Research in Health (R01 Clinical Trial Optional) Agency: NIH Institutions: NCINHLBINHGRINIANIAAANIAIDNIAMSNICHDNIDCDNIDCRNIDANIEHSNIMHNINDSNINRNIMHDNCCIHODPOBSSRORWH	05/08/19	05/07/22
Dissemination and Implementation Research in Health (R21 Clinical Trial Optional) Agency: NIH Institutions: NCINHGRINIANIAAANIAIDNIAMSNIDCDNIDANIEHSNIMHNINDSNINRFICNCCIHODPOBSSRORWH	05/08/19	05/07/22
DoD Breast Cancer, Breakthrough Award Level 3 Agency: AMRAA	05/07/19	09/25/19
DoD Breast Cancer, Breakthrough Award Level 4 Agency: AMRAA	05/07/19	09/25/19
DoD Breast Cancer, Breakthrough Award Levels 1 and 2 Agency: AMRAA	05/07/19	09/05/19
PHS 2019-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMNCCIHNCATSORIP	05/07/19	04/06/20
PHS 2019-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANICHDNIDCDNIDANIEHSNIGMSNIMHNINRNIMHDNCCIH	05/07/19	04/06/20
PHS 2019-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMNCCIHNCATSORIP	05/07/19	04/06/20
PHS 2019-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANICHDNIDCDNIDANIEHSNIGMSNIMHNINRNIMHDNCCIH	05/07/19	04/06/20
HLA and KIR Region Genomics in Immune-Mediated Diseases (U01 Clinical Trial Not Allowed) Agency: NIH Institutions: NIAIDNCININDS	05/02/19	09/04/19
Lasker Clinical Research Scholars Program (Si2/R00 Clinical Trial Optional) Agency: NIH Institutions: NCINEINHLBINHGRINIAIDNICHDNIDCRNIDDKNIEHSNIMHNINDSNINRNIMHD	05/01/19	08/30/19
Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Aggressive Cancer (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	05/01/19	12/10/21
DoD Spinal Cord Injury, Translational Research Award Agency: AMRAA	04/15/19	09/09/19
Basic and Translational Research on Adducts in Cancer Risk Identification and Prevention (R21 Clinical Trial Optional) Agency: NIH Institutions: NCINIEHS	04/11/19	11/08/21
Basic and Translational Research on Adducts in Cancer Risk Identification and Prevention (R01 Clinical Trial Optional) Agency: NIH Institutions: NCINIEHS	04/11/19	11/08/21
Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional) Agency: NIH Institutions: NCI	04/08/19	06/17/21
DOD Prostate Cancer, Idea Development Award Agency: AMRAA	04/05/19	09/19/19
Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional) Agency: NIH Institutions: NCI	03/28/19	11/20/19
Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) Agency: NIH Institutions: NCI	03/28/19	11/20/19
Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) Agency: NIH Institutions: NCI	03/28/19	11/20/19
ITCR: innovative algorithms (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	03/27/19	11/20/19
DoD Lung Cancer, Career Development Award Agency: AMRAA	03/22/19	08/21/19
DoD Lung Cancer, Idea Development Award Agency: AMRAA	03/22/19	08/21/19
DoD Lung Cancer, Translational Research Partnership Award Agency: AMRAA	03/22/19	08/21/19
DoD Lung Cancer, Investigator-Initiated Translational Research Award Agency: AMRAA	03/22/19	08/21/19
DoD Peer Reviewed Cancer, Career Development Award Agency: AMRAA	03/21/19	09/11/19
DoD Peer Reviewed Cancer, Horizon Award Agency: AMRAA	03/21/19	09/11/19
DoD Peer Reviewed Cancer, Idea Award with Special Focus Agency: AMRAA	03/21/19	09/11/19
DoD Peer Reviewed Cancer, Impact Award Agency: AMRAA	03/21/19	09/11/19
DoD Peer Reviewed Cancer, Translational Team Science Award Agency: AMRAA	03/21/19	09/11/19
Feasibility and Planning Studies for Development of Specialized Programs of Research Excellence (SPOREs) to Investigate Cancer Health Disparities (P20 Clinical Trial Optional) Agency: NIH Institutions: NCI	03/13/19	10/18/20
Mechanisms Underlying the Contribution of Sleep Disturbances to Pain (R21 Clinical Trial Optional) Agency: NIH Institutions: NCCIHNCINIANIAAANIDANIDCRNINDSNINROBSSRORWH	02/28/19	05/07/22
Mechanisms Underlying the Contribution of Sleep Disturbances to Pain (R01 Clinical Trial Optional) Agency: NIH Institutions: NCCIHNCINHLBINIANIAAANIDANIDCRNINDSNINROBSSRORWH	02/28/19	05/07/22
Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	02/27/19	11/08/21
Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	02/27/19	11/08/21
Microbial-based Cancer Therapy -Bugs as Drugs (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	02/22/19	05/07/22
Microbial-based Cancer Therapy -Bugs as Drugs (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	02/22/19	05/07/22
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions with NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30) Agency: NIH Institutions: NCCIHNCINHLBINIANIAAANICHDNIDCDNIDCRNIDDKNIEHSNIMHNIMHDORIP	02/22/19	01/07/22
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31) Agency: NIH Institutions: NCCIHNCINHGRINHLBINIANIAAANIAMSNICHDNIDCDNIDCRNIDDKNIEHSNIMHNIMHDNINDSNLMORIP	02/22/19	01/07/22
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32) Agency: NIH Institutions: NCCIHNCINHGRINHLBINIANIAAANIAMSNICHDNIDCDNIDCRNIDDKNIEHSNIGMSNIMHNIMHD	02/22/19	01/07/22
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions Without NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30) Agency: NIH Institutions: NCCIHNCINHLBINIANIAAANIAMSNICHDNIDCDNIDCRNIDDKNIEHSNIGMSNIMHNIMHDNINDSNLMORIP	02/22/19	01/07/22
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Senior Fellowship (Parent F33) Agency: NIH Institutions: NCINHLBINIANIAAANIAMSNIDCRNIEHS	02/21/19	01/07/22
Cyber-Physical Systems Agency: NSF	02/12/19	09/26/19
Biology of Bladder Cancer (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	02/05/19	05/07/22
Biology of Bladder Cancer (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	02/05/19	05/07/22
Provocative Questions (PQs) in Cancer with an Underlying HIV Infection (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	01/24/19	08/03/20
Improving Outcomes for Pediatric, Adolescent and Young Adult Cancer Survivors (U01 Clinical Trial Required) Agency: NIH Institutions: NCI	01/11/19	01/03/20
Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R01-Clinical Trial Not Allowed) Agency: NIH Institutions: NIDANIMHDNIMHNCINCCIHORWH	01/09/19	09/07/21
Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R21-Clinical Trial Not Allowed) Agency: NIH Institutions: NIDANINDSNIMHDNIMHNCINICHDORWH	01/09/19	09/07/21
Bioengineering Research Grants (BRG) (R01 Clinical Trial Required) Agency: NIH Institutions: NIBIBNCINIANIAAANINDS	01/08/19	05/07/21
Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NIBIBNIAAANIAMSNCINIDCRNIEHSNINDSNIA	01/08/19	01/07/22
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	01/08/19	01/07/22
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NCINIAMS	01/08/19	01/07/22
End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R21 Clinical Trial Optional) Agency: NIH Institutions: NINRNCI	01/08/19	01/07/22
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed) Agency: NIH Institutions: NCI	01/07/19	09/27/19
Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed) Agency: NIH Institutions: NCI	01/07/19	09/27/19
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed) Agency: NIH Institutions: NCI	01/07/19	09/27/19
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed) Agency: NIH Institutions: NCI	01/07/19	09/27/19
Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional) Agency: NIH Institutions: NCI	01/07/19	09/27/19
Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional) Agency: NIH Institutions: NCI	01/07/19	09/27/19
Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	01/07/19	09/27/19
Revisions for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional) Agency: NIH Institutions: NCI	01/07/19	09/27/19
Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trials Optional) Agency: NIH Institutions: NCI	01/07/19	09/27/19
Revisions for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional) Agency: NIH Institutions: NCI	01/07/19	09/27/19
Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 - Clinical Trial Required) Agency: NIH Institutions: NICHDNEININRNIDCDNIDANINDSNHLBINCINIANIMH	12/21/18	01/07/21
End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R01 Clinical Trial Optional) Agency: NIH Institutions: NINRNCI	12/21/18	01/07/22
Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required) Agency: NIH Institutions: NINRNCINIANICHDNIDCDNIDANIMHNINDSNHLBI	12/21/18	01/07/22
Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed) Agency: NIH Institutions: NIDCRNCINHLBINIANIAIDNIAMSNIBIBNICHDNIDCDNIDANIEHSNIMHNINDSNCCIHNINR	12/21/18	01/07/22
Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Required) Agency: NIH Institutions: NCINHLBINHGRINIANIAAANIBIBNICHDNIDCDNIDCRNIDDKNIDANIMHNINDSNCCIHNIEHS	12/20/18	01/07/22
Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Not Allowed) Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNCCIH	12/20/18	01/07/22
NIH Pathway to Independence Award (Parent K99/R00 - Independent Clinical Trial Not Allowed) Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIAMSNIAIDNIBIBNCCIH	12/20/18	01/07/22
NIH Pathway to Independence Award (Parent K99/R00 - Independent Clinical Trial Required) Agency: NIH Institutions: NCINHLBINHGRINIANIAAANIAMSNIBIBNICHDNIDANCCIH	12/20/18	01/07/22
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	12/17/18	01/07/22
Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	12/17/18	01/07/22
Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	12/17/18	01/07/22
FY19-FY20 Department of Defense HIV/AIDS Prevention Program: Military Specific HIV/AIDS Prevention, Care, and Treatment Program for Non-PEPFAR (President's Emergency Plan for AID Relief) Funded Countries Agency: SUP	12/13/18	09/30/20
Physical Sciences-Oncology Network (PS-ON): Physical Sciences-Oncology Projects (PS-OP) (U01 Clinical Trial Optional) Agency: NIH Institutions: NCI	12/12/18	07/30/20
Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed) Agency: NIH Institutions: FICNCINHGRINIDCRNIEHSNIMHNINDSORWH	12/11/18	11/04/20
HEAL Initiative: Clinical Devices to Treat Pain (UH3 Clinical Trial Optional) Agency: NIH Institutions: NINDSNCINEINIAAANIAMSNIBIBNICHDNIDCRNIDDKNIDANIMHNINRNCCIHNCATSORWH	12/10/18	02/22/21
HEAL Initiative: Translational Devices to Treat Pain (UG3/UH3 Clinical Trial Optional) Agency: NIH Institutions: NINDSNCINEINIAAANIAMSNIBIBNICHDNIDCRNIDDKNIDANIMHNINRNCCIHNCATSORWH	12/10/18	02/22/21
HEAL Initiative: Translational Development of Devices to Treat Pain (U18 Clinical Trial Not Allowed) Agency: NIH Institutions: NIBIBNIAAANIAMSNCINEINICHDNIDCRNIDDKNIDANINDSNCCIHNCATS	12/10/18	02/22/21
HEAL Initiative: Translational Devices to Treat Pain (U44 Clinical Trial Optional) Agency: NIH Institutions: NINDSNCINEINIAAANIAMSNIBIBNICHDNIDCRNIDDKNIDANIMHNINRNCCIHNCATSORWH	12/10/18	02/22/21
Leveraging Health Information Technology (Health IT) to Address Minority Health and Health Disparities (R01 Clinical Trial Optional) Agency: NIH Institutions: NIMHDNCIOBSSR	11/28/18	03/04/21
Small Research Grants for Analyses of Data for the Gabriella Miller Kids First Data Resource (R03 - Clinical Trial Not Allowed) Agency: NIH Institutions: NICHDNCINHLBINIAAANIDCRNINDS	11/16/18	09/07/19
Research Project Grant (Parent R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMNCCIHORIPICs	11/05/18	01/07/22
Emerging Global Leader Award (K43 Independent Clinical Trial Required) Agency: NIH Institutions: FICNCINHGRINIDCRNIEHSNIMHNINDSORWH	11/02/18	11/04/20
Commercializing Understudied Proteins from the Illuminating the Druggable Genome Project (IDG) (R43/R44 Clinical Trial Not Allowed) Agency: NIH Institutions: NIDCRNCINIMHNLMNCATS	10/24/18	09/05/21
Commercializing Understudied Proteins from the Illuminating the Druggable Genome Project (IDG) (R41/R42 Clinical Trial Not Allowed) Agency: NIH Institutions: NIDCRNCINIMHNLMNCATS	10/24/18	09/05/21
Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial Not Allowed) Agency: NIH Institutions: NCINEINHGRINIANIAAANIAIDNIAMSNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNCCIHNCATSNHLBIORIPNICHD	10/17/18	02/02/21
Opportunities for Collaborative Research at the NIH Clinical Center (U01 Clinical Trial Optional) Agency: NIH Institutions: NICHDNCINEINHLBINHGRINIAAANIAMSNIBIBNIDCDNIDCRNIDANIMHNINDSNCCIHODSORWH	10/05/18	04/15/21
Mechanisms of Disparities in Etiology and Outcomes of Lung Cancer in the U.S.: The Role of Risk and Protective Factors (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NIMHDNCI	10/05/18	03/04/21
Mechanisms of Disparities in Etiology and Outcomes of Lung Cancer in the U.S.: The Role of Risk and Protective Factors (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NIMHDNCI	10/05/18	03/04/21
Pre-application: Opportunities for Collaborative Research at the NIH Clinical Center (X02 Clinical Trial Optional) Agency: NIH Institutions: NICHDNCINEINHLBINHGRINIAAANIAMSNIBIBNIDCDNIDCRNIDANIMHNINDSNCCIHODSORWH	10/05/18	12/11/20
Applying a Biopsychosocial Perspective to Self-Management of Chronic Pain (R21 Clinical Trial Optional) Agency: NIH Institutions: NINRNCINCCIHOBSSR	10/01/18	01/07/22
Applying a Biopsychosocial Perspective to Self-Management of Chronic Pain (R01 Clinical Trial Optional) Agency: NIH Institutions: NINRNCINCCIHOBSSR	10/01/18	01/07/22
Biobehavioral Basis of Chronic Pain (R21 Clinical Trial Optional) Agency: NIH Institutions: NINRNCINIAMSNCCIHOBSSR	10/01/18	01/07/22
Biobehavioral Basis of Chronic Pain (R01 Clinical Trial Optional) Agency: NIH Institutions: NINRNCINIAMSNCCIHOBSSR	10/01/18	01/07/22
FY19-FY20 Department of Defense HIV/AIDS Prevention Program: Military Specific HIV/AIDS Prevention, Care, and Treatment Program for PEPFAR (President's Emergency Plan for AIDS Relief) Funded Countries Agency: SUP	09/28/18	09/30/20
Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	09/28/18	07/11/21
Increasing Uptake of Evidence-Based Screening in Diverse Adult Populations (R01 Clinical Trial Optional) Agency: NIH Institutions: ODPNCINIANIAAANIDCRNIDANIMHNIMHD	09/21/18	01/07/22
Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NINDSNCINEINIANIAAANIAMSNICHDNIDCRNIDDKNIDANINRNLMNCCIH	09/19/18	11/12/19
Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NINDSNCINEINIANIAAANIAMSNICHDNIDCRNIDDKNIDANINRNLMNCCIH	09/19/18	11/12/19
Analytical and/or Clinical Validation of a Candidate Biomarker for Pain (R61/R33 Clinical Trial Optional) Agency: NIH Institutions: NINDSNCINEINHLBINIANIAAANIAMSNICHDNIDCRNIDDKNIDANINRNLMNCCIHOBSSRORWH	09/19/18	03/12/20
Quantitative Imaging Tools and Methods for Cancer Response Assessment (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	09/12/18	05/07/20
Developing the Therapeutic Potential of the Endocannabinoid System for Pain Treatment (R01 - Clinical Trial Optional) Agency: NIH Institutions: NIDANCINCCIHNIAAANICHD	09/10/18	09/07/21
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	09/07/18	08/11/21
Feasibility Studies to Build Collaborative Partnerships in Cancer Research (P20 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	09/05/18	11/13/20
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMFICNCCIHNCATSORIP	08/22/18	09/07/21
Advancing Translational and Clinical Probiotic/Prebiotic and Human Microbiome Research (R01 Clinical Trial Optional) Agency: NIH Institutions: NCINCCIHODS	08/14/18	09/07/21
Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	08/07/18	09/07/21
Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	08/07/18	09/07/21
Discovery of Biomarkers, Biomarker Signatures, and Endpoints for Pain (R61/R33 Clinical Trial Optional) Agency: NIH Institutions: NINDSNCINEINHLBINIANIAAANIAMSNIBIBNICHDNIDCRNIDDKNIDANINRNLMNCATSNCCIH	08/02/18	03/12/20
2018 Human Exploration Research Opportunities (HERO) Agency: JSC	08/01/18	09/05/19
Advancing Mechanistic Probiotic/Prebiotic and Human Microbiome Research (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NIDCRNCINIAMSNIDAODS	07/25/18	09/07/21
Biologic Factors Underlying Dental, Oral, and Craniofacial Health Disparities (R21 - Clinical Trial Not Allowed) Agency: NIH Institutions: NIDCRNIMHD	07/25/18	09/07/21
Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	07/24/18	03/08/21
Diet and Physical Activity Assessment Methodology (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NIDDKNCINIAAANIMHDNCCIH	07/17/18	09/07/21
Diet and Physical Activity Assessment Methodology (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NIDDKNCINIAAANIMHDNINR	07/17/18	09/07/21
Time-Sensitive Obesity Policy and Program Evaluation (R01 Clinical Trial Not Allowed) Agency: NIH Institutions: NIDDKNCINICHDODPOBSSR	07/12/18	09/10/21
Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research (R01 - Clinical Trial Optional) Agency: NIH Institutions: ODPNCINIDCRNIDANIMHD	06/29/18	06/27/20
Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R01 - Clinical Trial Not Allowed) Agency: NIH Institutions: ODPNCINIDCRNIDANIEHS	06/29/18	06/27/20
Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R21 - Clinical Trial Not Allowed) Agency: NIH Institutions: ODPNCINIDCRNIDANIEHS	06/29/18	06/27/20
Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research (R21 - Clinical Trial Optional) Agency: NIH Institutions: ODPNCINIDCRNIDANIMHD	06/29/18	06/27/20
Administrative Supplements to Support Cancer Disparity Collaborative Research (Clinical Trial Optional) Agency: NIH Institutions: NCI	06/28/18	09/10/20
Oncology Co-Clinical Imaging Research Resources to Encourage Consensus on Quantitative Imaging Methods and Precision Medicine (U24 - Clinical Trial Optional) Agency: NIH Institutions: NCI	06/28/18	06/14/21
Administrative Supplements to Promote Diversity in Small Businesses-SBIR/STTR (Admin Supp Clinical Trial Not Allowed) Agency: NIH Institutions: NCINEINHGRINIANIAAANIAIDNIBIBNIDCRNIDANIGMSNINDSNINRNIMHDNCCIHNCATS	06/20/18	09/04/21
The Role of Epitranscriptomics in Development and Disease (R01 - Clinical Trial Not Allowed) Agency: NIH Institutions: NICHDNCINEI	06/14/18	06/03/21
NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required) Agency: NIH Institutions: ODS	06/13/18	11/04/19
Administrative Supplements for Research on Dietary Supplements (Admin. Supp.- Clinical Trial Not Allowed) Agency: NIH Institutions: ODSNCINEINHLBINIANIAAANIAIDNIAMSNIDCDNIDCRNIDDKNIEHSFICNCCIHORIP	06/05/18	04/15/20
Administrative Supplements for Validation Studies of Analytical Methods for Dietary Supplement Constituents (Admin Supp - Clinical Trial Not Allowed) Agency: NIH Institutions: ODSNCINIDDKNIEHSNCCIH	06/05/18	04/15/20
Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (R41/R42 - Clinical Trial Optional) Agency: NIH Institutions: NCI	05/24/18	01/05/21
Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (R43/R44 - Clinical Trial Optional) Agency: NIH Institutions: NCI	05/24/18	01/05/21
Precision Imaging of Oral Lesions (R01- Clinical Trial Not Allowed) Agency: NIH Institutions: NIDCRNIBIBNCI	05/16/18	09/07/21
Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (Collaborative U54 Clinical Trial Optional) Agency: NIH Institutions: NCI	04/30/18	01/09/20
Harnessing Big Data to Halt HIV (R01 Clinical Trial Optional) Agency: NIH Institutions: NIAIDNCINIMH	04/20/18	05/07/21
Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression (R01 Clinical Trial Optional). Agency: NIH Institutions: NCINIANIDCRNINR	04/03/18	05/07/21
Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression (R21 Clinical Trial Optional). Agency: NIH Institutions: NCINIANIDCRNINR	04/03/18	05/07/21
Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	03/29/18	11/19/20
Food Specific Molecular Profiles and Biomarkers of Food and Nutrient Intake, and Dietary Exposure (R01 Clinical Trial Optional) Agency: NIH Institutions: NIDDKNCINCCIHODS	03/29/18	01/27/20
Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health (R21 Clinical Trial Optional) Agency: NIH Institutions: OBSSRNCINIANIAAANIAIDNIDANIMHNINRNIMHD	03/28/18	05/07/21
Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health (R01 Clinical Trial Optional) Agency: NIH Institutions: OBSSRNCINIANIAAANIAIDNIDANIMHNINRNIMHDNCCIH	03/28/18	05/07/21
Research on the Health of Transgender and Gender Nonconforming Populations (R21 Clinical Trial Optional) Agency: NIH Institutions: NICHDNCINHGRINIANIAAANIAIDNIDCDNIEHSNIMHDNIMHNINRSGMROOARORWH	03/28/18	01/07/21
Research on the Health of Transgender and Gender Nonconforming Populations (R01 Clinical Trial Optional) Agency: NIH Institutions: NICHDNCINHGRINIANIAAANIAIDNIDCDNIEHSNIMHDNIMHNINRSGMROOARORWH	03/28/18	01/07/21
Exploratory/Developmental Clinical Research Grants in Obesity (R21 Clinical Trial Optional) Agency: NIH Institutions: NIDDKNCINICHDODS	03/27/18	05/07/21
SBIR Technology Transfer (R43/R44 Clinical Trial Not Allowed) Agency: NIH Institutions: NINDSNCINEINIAAANIDCRNIDANINR	03/06/18	04/05/21
Fundamental Mechanisms of Affective and Decisional Processes in Cancer Control (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	02/27/18	10/11/19
Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R21 - Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	02/23/18	05/07/21
Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R01 - Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	02/23/18	05/07/21
U.S. Tobacco Control Policies to Reduce Health Disparities (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	02/21/18	06/15/20
U.S. Tobacco Control Policies to Reduce Health Disparities (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	02/21/18	06/15/20
Smart and Connected Health Agency: NSF	02/21/18	12/11/19
Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	02/13/18	11/19/20
Basic Research in Cancer Health Disparities (R01 Clinical Trials Not Allowed) Agency: NIH Institutions: NCI	02/13/18	11/19/20
NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed) Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNINDSNIMHDNLMNCCIHNCATSORIP	02/09/18	01/07/21
Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 - Clinical Trial Optional) Agency: NIH Institutions: NIANCI	02/08/18	09/07/19
Research Infrastructure Development for Interdisciplinary Aging Studies (R21/R33 - Clinical Trial Optional) Agency: NIH Institutions: NIANCI	02/08/18	09/07/19
Perception and Cognition Research to Inform Cancer Image Interpretation (R21 Clinical Trial Optional) Agency: NIH Institutions: NCINIBIB	02/07/18	09/26/19
Perception and Cognition Research to Inform Cancer Image Interpretation (R01 Clinical Trial Optional) Agency: NIH Institutions: NCINIBIB	02/07/18	09/26/19
Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	02/05/18	05/07/21
Successor-in-Interest (Type 6 Parent Clinical Trial Optional) Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMFICNCCIHNCATSORIPOBSSRORWH	01/26/18	01/25/21
Change of Grantee Organization (Type 7 Parent Clinical Trial Optional) Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMFICNCCIHNCATSORIPOBSSRORWH	01/25/18	01/25/21
Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp - Clinical Trial Optional) Agency: NIH Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMFICNCCIHNCATSORIPOBSSRORWH	01/25/18	01/25/21
Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed ) Agency: NIH Institutions: ORWHNCINEINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMNCCIHORIP	01/25/18	09/07/21
Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required) Agency: NIH Institutions: NCI	01/05/18	01/07/21
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trials Required) Agency: NIH Institutions: NCI	01/05/18	01/07/21
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional) Agency: NIH Institutions: NCINIDCRNIBIB	12/21/17	01/07/21
International Research Scientist Development Award (IRSDA) (K01) - Independent Clinical Trial Not Allowed Agency: NIH Institutions: FICNCI	12/21/17	03/06/20
International Research Scientist Development Award (IRSDA) (K01) - Independent Clinical Trial Required Agency: NIH Institutions: FICNCI	12/21/17	03/06/20
Early-life Factors and Cancer Development Later in Life (R03 - Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	12/20/17	01/07/21
Early-life Factors and Cancer Development Later in Life (R21 - Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	12/20/17	01/07/21
Early-life Factors and Cancer Development Later in Life (R01 - Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	12/20/17	01/07/21
Synthetic Biology for Engineering Applications (R01) (Clinical Trial Optional) Agency: NIH Institutions: NIBIBNCINCCIH	12/15/17	09/07/20
Advancing the Science of Geriatric Palliative Care (R21 - Clinical Trial Optional) Agency: NIH Institutions: NIANINRNIMHDNCI	12/15/17	05/07/20
Advancing the Science of Geriatric Palliative Care (R01 - Clinical Trial Optional) Agency: NIH Institutions: NIANCCIHNINRNIMHDNCINHLBI	12/15/17	05/07/20
Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	12/11/17	05/07/21
Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	12/11/17	05/07/21
The NCI Transition Career Development Award (K22 - Independent Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	12/06/17	03/12/21
The NCI Transition Career Development Award (K22 Independent Clinical Trial Required) Agency: NIH Institutions: NCI	12/06/17	03/12/21
Cancer Research Education Grants Program - Curriculum or Methods Development (R25) Agency: NIH Institutions: NCI	12/05/17	01/07/21
Cancer Research Education Grants Program - Research Experiences (R25) Agency: NIH Institutions: NCI	12/05/17	01/07/21
Cancer Research Education Grants Program - Courses for Skills Development (R25) Agency: NIH Institutions: NCI	12/05/17	01/07/21
Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R01 Clinical Trial Optional) Agency: NIH Institutions: NIDANCINIAAA	11/30/17	11/13/20
Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional) Agency: NIH Institutions: NIANCINCCIHNIDCRNIDANIMHNIMHDNINDSNINR	11/29/17	09/07/20
Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional) Agency: NIH Institutions: NIANCINIAAANIDCRNIDDKNIDANIMHNIMHDNINDSNINR	11/29/17	09/07/20
Quantitative Imaging Tools and Methods for Cancer Therapy Response Assessment (UG3/UH3 Clinical Trial Optional) Agency: NIH Institutions: NCI	11/29/17	01/09/20
Tobacco Use and HIV in Low and Middle Income Countries (R21 Clinical Trial Optional) Agency: NIH Institutions: NCINIDA	11/28/17	01/07/20
Tobacco Use and HIV in Low and Middle Income Countries (R01 Clinical Trial Optional) Agency: NIH Institutions: NCINIDA	11/28/17	01/07/20
NCI Small Grants Program for Cancer Research (NCI Omnibus R03 Clinical Trial Optional) Agency: NIH Institutions: NCI	11/21/17	01/07/20
Methodology and Measurement in the Behavioral and Social Sciences (R21) Clinical Trials Optional Agency: NIH Institutions: OBSSRNCINEINIANIAAANIDCDNCCIHODPORWHOBSSR	11/21/17	09/07/19
Methodology and Measurement in the Behavioral and Social Sciences (R01) Clinical Trials Optional Agency: NIH Institutions: OBSSRNCINEINIANIAAANIDCDNCCIHODPORWH	11/21/17	09/07/19
Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32) Agency: NIH Institutions: NCINEINHGRINIANIAIDNIAMSNIBIBNICHDNIDCDNIDDKNIDANIEHSNIGMSNIMHNINRNCCIHNHLBIORIPNINDSNIAAA	11/21/17	01/07/21
NCI Transition Career Development Award to Promote Diversity (K22 - No Clinical Trials) Agency: NIH Institutions: NCI	11/20/17	01/07/21
NCI Transition Career Development Award to Promote Diversity (K22 Clinical Trial Required) Agency: NIH Institutions: NCI	11/20/17	01/07/21
NCI Mentored Research Scientist Development Award to Promote Diversity (K01) Agency: NIH Institutions: NCI	11/17/17	01/07/21
NCI Mentored Research Scientist Development Award to Promote Diversity (K01) Agency: NIH Institutions: NCI	11/17/17	01/07/21
Target Assessment, Engagement and Data Replicability to Improve Substance Use Disorders Treatment Outcomes (R33 Clinical Trial Optional) Agency: NIH Institutions: NIDANCINIAAA	11/17/17	09/07/19
Target Assessment, Engagement and Data Replicability to Improve Substance Use Disorders Treatment Outcomes (R21/R33 Clinical Trial Optional) Agency: NIH Institutions: NIDANCINIAAA	11/17/17	09/07/19
Integrative Research on Polysubstance Abuse and Addiction (R21/R33 Clinical Trial Optional) Agency: NIH Institutions: NIDANIAAANCI	11/17/17	01/07/20
Fertility Status as a Marker for Overall Health (R21 Clinical Trial Optional) Agency: NIH Institutions: NICHDNIEHSODP	11/15/17	05/07/20
Mechanisms, Models, Measurement, and Management in Pain Research (R01 Clinical Trial Optional) Agency: NIH Institutions: NINRNIANIAMSNIDDKNIDANIDCRNINDSNCCIHNIMHDNCI	11/07/17	01/07/20
Mechanisms, Models, Measurement, and Management in Pain Research (R21 Clinical Trial Optional) Agency: NIH Institutions: NCININRNIANIAMSNIDANIDCRNINDSNCCIHNIMHD	11/07/17	01/07/20
Palliative Care Needs of Individuals with Advanced Rare Diseases and Their Family Caregivers (R01 Clinical Trial Optional) Agency: NIH Institutions: NINRNCI	11/07/17	01/07/20
Palliative Care Needs of Individuals with Rare Advanced Diseases and Their Family Caregivers (R21 Clinical Trial Optional) Agency: NIH Institutions: NINRNCI	11/07/17	01/07/20
Early Phase Clinical Trials in Imaging and Image-Guided Interventions (R01 Clinical Trial Required) Agency: NIH Institutions: NCI	11/06/17	02/14/20
Reducing Overscreening for Breast, Cervical, and Colorectal Cancers among Older Adults (R21 Clinical Trial Optional) Agency: NIH Institutions: NCINIA	11/03/17	01/07/20
Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	11/03/17	01/07/20
Reducing Overscreening for Breast, Cervical, and Colorectal Cancers among Older Adults (R01 Clinical Trial Optional) Agency: NIH Institutions: NCINIA	11/03/17	01/07/20
Oral Anticancer Agents: Utilization, Adherence, and Health Care Delivery (R21 Clinical Trial Optional) Agency: NIH Institutions: NCI	11/03/17	01/07/20
NCCIH Mind and Body Clinical Trial Cooperative Agreement (U01 Clinical Trial Required) Agency: NIH Institutions: NCCIH	11/02/17	02/29/20
Potential Effects of Metformin on Aging and Age-Related Conditions: Small-Scale Clinical Studies and Secondary Analysis of Controlled Clinical Studies (R01 Clinical Trial Optional) Agency: NIH Institutions: NIANCI	11/01/17	05/07/20
Addressing Health Disparities through Effective Interventions Among Immigrant Populations (R01 Clinical Trial Optional) Agency: NIH Institutions: NIMHDNCINIAAANIDANIEHS	11/01/17	01/07/20
Addressing Health Disparities through Effective Interventions Among Immigrant Populations (R21 Clinical Trial Optional) Agency: NIH Institutions: NIMHDNCINIAAANIDANIEHS	11/01/17	01/07/20
Academic-Industrial Partnerships to Translate and Validate in vivo Cancer Imaging Systems (R01 Clinical Trial Optional) Agency: NIH Institutions: NCINIDCRNIDDK	11/01/17	11/05/19
Nutrigenetics and Nutrigenomics Approaches for Nutrition Research (R01 Clinical Trial Optional) Agency: NIH Institutions: NIDDKNCINCCIHODS	11/01/17	09/07/19
Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional) Agency: NIH Institutions: NIDANCINIAAA	11/01/17	09/07/19
NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 - No Independent Clinical Trials) Agency: NIH Institutions: NCI	10/31/17	01/07/21
NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 - Clinical Trials Required) Agency: NIH Institutions: NCI	10/31/17	01/07/21
National Cancer Institute Program Project Applications (P01 Clinical Trial Optional) Agency: NIH Institutions: NCI	10/30/17	01/07/20
Simulation Modeling and Systems Science to Address Health Disparities (R01-Clinical Trial Not Allowed) Agency: NIH Institutions: NIMHDNCINHLBINIANIDCDNIDANIMHNLMODPOBSSRNIAAANIBIB	10/20/17	09/07/19
Testing Interventions for Health-Enhancing Physical Activity (R01 - Clinical Trial Optional) Agency: NIH Institutions: ODPNCINIANIAAANICHDNIDANIMHDNCCIH	10/17/17	01/07/21
Specialized Programs of Research Excellence (SPOREs) in Human Cancers for years 2018, 2019 and 2020 (P50) Agency: NIH Institutions: NCINIDCR	10/12/17	01/07/21
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 - Clinical Trials Not Allowed Agency: NIH Institutions: NCI	10/12/17	10/08/20
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 - Clinical Trials Not Allowed) Agency: NIH Institutions: NCI	10/12/17	10/08/20
Developing Interventions for Health-Enhancing Physical Activity (R21/R33 - Clinical Trial Optional) Agency: NIH Institutions: ODPNCINIANIAAANIDANCCIH	10/10/17	01/07/21
Innovative Molecular Analysis Technology Development for Cancer Research and Clinical Care (R43/R44 Clinical Trial Not Allowed) Agency: NIH Institutions: NCI	10/03/17	01/07/21
Multilevel Interventions in Cancer Care Delivery: Follow-up to Abnormal Screening Tests (R01 Clinical Trial Optional) Agency: NIH Institutions: NCI	09/29/17	01/07/21
Research to Improve Native American Health (R21 Clinical Trial Optional) Agency: NIH Institutions: NCINIAAANIDANIEHSNIMHNIMHDOBSSRNIDCR	09/29/17	05/14/20
Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) Agency: NIH Institutions: NCINIAAANIDANIEHSNIMHNIMHDOBSSRNINRNIDCR	09/29/17	05/14/20
Collaborative Minority Health and Health Disparities Research with Tribal Epidemiology Centers (R01) Agency: NIH Institutions: NIMHDNCINIAAANIDANIEHS	09/13/17	12/04/19
Collaborative Minority Health and Health Disparities Research with Tribal Epidemiology Centers (R21) Agency: NIH Institutions: NIMHDNCINIAAANIDANIEHS	09/13/17	12/04/19
Clinical and Epidemiological Research on Chronic Disease in the Caribbean (R01) Agency: NIH Institutions: NIMHDNCINHLBINIANINR	08/25/17	11/15/19
Stimulating Access to Research in Residency (StARR) (R38) Agency: NIH Institutions: NHLBINCINIAIDNIA	08/23/17	05/12/20
Biology of Lung, and Head and Neck Preneoplasias (R21) Agency: NIH Institutions: NCI	08/16/17	01/07/21
Biology of Lung, and Head and Neck Preneoplasias (R01) Agency: NIH Institutions: NCI	08/15/17	01/07/21
The Interplay of Cell Death Pathways in Cancer Cell Survival and Resistance to Therapy (R01) Agency: NIH Institutions: NCI	08/04/17	09/07/20
The Interplay of Cell Death Pathways in Cancer Cell Survival and Resistance to Therapy (R21) Agency: NIH Institutions: NCI	08/04/17	09/07/20
Ethical, Legal, and Social Implications (ELSI) of Genomics Small Research Grant Program (R03) Agency: NIH Institutions: NHGRINCINIANIAIDNICHDNIDCDNIEHSFIC	08/01/17	09/07/20
Ethical, Legal, and Social Implications (ELSI) of Genomics Research Project Grant Program (R01) Agency: NIH Institutions: NHGRINCINIANICHDNIEHSNINDSNIMHD	08/01/17	09/07/20
Ethical, Legal, and Social Implications (ELSI) of Genomics Exploratory/Developmental Research Grant Program (R21) Agency: NIH Institutions: NHGRINCINIANIAIDNICHDNIDCDNIEHSNINDSNIMHD	08/01/17	09/07/20
Assay development and screening for discovery of chemical probes or therapeutic agents (R01) Agency: NIH Institutions: NCINIAIDNIDCDNIDANIMH	07/27/17	09/07/20
Using Small Molecules and Molecular Genetics to Identify Novel Targets and Mechanisms Contributing to Tumor Immune Evasion (R01) Agency: NIH Institutions: NCI	07/20/17	09/07/20
Discovery of Small Molecule Immunomodulators for Cancer Therapy (R01) Agency: NIH Institutions: NCI	07/20/17	09/07/20
Multidisciplinary Studies of HIV/AIDS and Aging (R21) Agency: NIH Institutions: NIANCINIAAANIAMSNIDCRNIDANIMHNIMHDNINDSNINR	06/23/17	09/07/20
Multidisciplinary Studies of HIV/AIDS and Aging (R01) Agency: NIH Institutions: NIANCINCCIHNIAMSNIDCRNIDANIMHNIMHDNINDSNINR	06/23/17	09/07/20
Integration of Individual Residential Histories into Cancer Research (R21) Agency: NIH Institutions: NCI	06/22/17	09/07/20
Integration of Individual Residential Histories into Cancer Research (R01) Agency: NIH Institutions: NCI	06/22/17	09/07/20
Leveraging Population-based Cancer Registry Data to Study Health Disparities (R01) Agency: NIH Institutions: NCI	05/16/17	09/07/20
Leveraging Population-based Cancer Registry Data to Study Health Disparities (R21) Agency: NIH Institutions: NCI	05/16/17	09/07/20
Genomic Community Resources (U24) Agency: NIH Institutions: NHGRINCI	05/08/17	01/25/20
Collaborative Research Projects to Enhance Applicability of Mammalian Models for Translational Research (Collaborative R01) Agency: NIH Institutions: NCI	04/04/17	05/07/20
Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01) Agency: NIH Institutions: NCI	04/03/17	05/07/20
Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R01) Agency: NIH Institutions: NCINHGRINIDCR	03/30/17	05/07/20
Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R21) Agency: NIH Institutions: NCINHGRINIDCR	03/30/17	05/07/20
Innovative Research in Cancer Nanotechnology (IRCN) (R01) Agency: NIH Institutions: NCI	03/30/17	05/21/20
Core Infrastructure and Methodological Research for Cancer Epidemiology Cohorts (U01) Agency: NIH Institutions: NCI	03/29/17	05/07/20
Mechanisms of Alcohol-associated Cancers (R21) Agency: NIH Institutions: NIAAANCI	03/13/17	09/07/20
Mechanisms of Alcohol-associated Cancers (R01) Agency: NIH Institutions: NIAAANCI	03/13/17	09/07/20
Inter-organelle Communication in Cancer (R21) Agency: NIH Institutions: NCI	03/07/17	01/15/20
Inter-organelle Communication in Cancer (R01) Agency: NIH Institutions: NCI	03/07/17	01/15/20
Development of Highly Innovative Tools and Technology for Analysis of Single Cells (STTR) (R41/R42) Agency: NIH Institutions: NIMHNCINHGRINIAMSNIDCRNIDDKNIEHSNCCIHNCATS	02/01/17	01/05/20
Development of Highly Innovative Tools and Technology for Analysis of Single Cells (SBIR) (R43/R44) Agency: NIH Institutions: NIMHNCINEINHGRINIAMSNIDCRNIDANIDDKNIEHSNIGMSNCCIHNCATS	02/01/17	01/05/20
Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30) Agency: NIH Institutions: NCI	12/21/16	01/07/20
Fertility Status as a Marker for Overall Health (R01) Agency: NIH Institutions: NICHDNIEHSODP	12/19/16	05/07/20
Tobacco Use and HIV in Low and Middle Income Countries (R01) Agency: NIH Institutions: NCINIDA	12/15/16	01/07/20
Tobacco Use and HIV in Low and Middle Income Countries (R21) Agency: NIH Institutions: NCINIDA	12/15/16	01/07/20
National Cancer Institute Youth Enjoy Science Research Education Program (R25) Agency: NIH Institutions: NCI	11/25/16	09/25/19
Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant Populations (R01) Agency: NIH Institutions: NIMHDNCINIAAANIDCRNIDANIEHS	11/01/16	01/07/20
Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant Populations (R21) Agency: NIH Institutions: NIMHDNCINIAAANIDCRNIDANIEHS	11/01/16	01/07/20
Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01) Agency: NIH Institutions: NCI	10/04/16	10/28/19
Kidney Precision Medicine Project - Technology Development and Validation (R43/R44) Agency: NIH Institutions: NIDDK	09/28/16	01/05/20
Kidney Precision Medicine Project - Technology Development and Validation (R41/R42) Agency: NIH Institutions: NIDDK	09/28/16	01/05/20
Support of Competitive Research (SCORE) Pilot Project Award (SC2) Agency: NIH Institutions: NIGMSNCINHLBINIANIAIDNICHDNIDCDNIDCRNIDDKNIDANIEHSNIMHNINDS	09/21/16	09/07/19
Support of Competitive Research (SCORE) Research Advancement Award (SC1) Agency: NIH Institutions: NIGMSNCINHLBINIANIAIDNICHDNIDCDNIDCRNIDDKNIDANIMHNINDSNIEHS	09/21/16	09/07/19
"High" or "Medium" Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers (R21) Agency: NIH Institutions: NCINIDCR	09/07/16	09/07/19
"High" or "Medium" Priority AIDS Research on Non-AIDS-defining or AIDS-defining Cancers (R01) Agency: NIH Institutions: NCINIDCR	09/07/16	09/07/19
Secondary Analyses of Alcohol and Chronic Disease (R03) Agency: NIH Institutions: NIAAANCI	08/10/16	09/07/19
Secondary Analyses of Alcohol and Chronic Disease (R01) Agency: NIH Institutions: NIAAANCI	08/10/16	09/07/19
Factors Underlying Differences in Female and Male Presentation for Dental, Oral, and Craniofacial Diseases and Conditions (R01) Agency: NIH Institutions: NIDCRNIAORWH	05/27/16	09/07/19
Factors Underlying Differences in Female and Male Presentation for Dental, Oral, and Craniofacial Diseases and Conditions (R21) Agency: NIH Institutions: NIDCRNIAORWH	05/27/16	09/07/19
Serious Adverse Drug Reaction Research (R21) Agency: NIH Institutions: NHGRINCINIAIDNIAMSNINDS	05/19/16	09/07/19
Serious Adverse Drug Reaction Research (R01) Agency: NIH Institutions: NHGRINCINIAIDNIAMSNINDSNIMHD	05/19/16	09/07/19
Mechanisms of Cancer and Treatment-related Symptoms and Toxicities (R21) Agency: NIH Institutions: NCI	05/16/16	09/07/19
Metabolic Reprogramming to Improve Immunotherapy (R21) Agency: NIH Institutions: NCI	05/06/16	09/07/19
Metabolic Reprogramming to Improve Immunotherapy (R01) Agency: NIH Institutions: NCI	05/06/16	09/07/19
The Role of Mobile Genetic Elements in Cancer (R21) Agency: NIH Institutions: NCINIA	05/05/16	09/07/19
The Role of Mobile Genetic Elements in Cancer (R01) Agency: NIH Institutions: NCINIA	05/05/16	09/07/19

TOP